Elanco Animal Health Incorporated Common Stock (NY:ELAN)

22.02 -0.12 (-0.56%)

Delayed Quote Updated: 9:40 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health

February 29, 2024

From Ancora Holdings Group, LLC

Via Business Wire

Breaking Down Elanco Animal Health: 6 Analysts Share Their Views ↗

February 27, 2024

Via Benzinga

Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript ↗

February 26, 2024

ELAN earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

This Pet Health Company Sees Growing Demand For Farm-Animal Products, Cost Savings From Restructuring ↗

February 26, 2024

Elanco Animal Health reports Q4 2023 revenue of $1.035 billion, exceeding consensus. Explore insights into pet and farm animal segments, profit margins, and 2024 guidance.

Via Benzinga

US Stocks Could Pause For Breather After Record Rally: Analyst Says 'No Doubt' That 2024 Shaping Up To 'Best Year Since 1999' ↗

February 26, 2024

The record run could introduce caution as the market heads into one of the seasonally weaker month of the year, with index futures lower on Monday.

Via Benzinga

Earnings Outlook For Elanco Animal Health ↗

February 23, 2024

Via Benzinga

Analyst Expectations For Elanco Animal Health's Future ↗

January 05, 2024

Via Benzinga

Earnings Scheduled For February 26, 2024 ↗

February 26, 2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.

Via Benzinga

Analyst Expectations for Elanco Animal Health's Future ↗

December 07, 2023

Via Benzinga

Stifel Maintains Hold Rating for Elanco Animal Health: Here's What You Need To Know ↗

October 30, 2023

Via Benzinga

Elanco Animal Health To Offload Aqua Business For $1.3B, Plans To Lower Debt Burden ↗

February 05, 2024

"Merck Animal Health expands aqua portfolio with the $1.3 billion acquisition of Elanco's aqua business. Expected completion by mid-2024."

Via Benzinga

Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday ↗

February 05, 2024

U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday.

Via Benzinga

Topics Stocks

Merck Animal Health to Acquire Elanco’s Aqua Business

February 05, 2024

From Merck & Co., Inc.

Via Business Wire

Goldman Sachs Maintains Sell Rating for Elanco Animal Health: Here's What You Need To Know ↗

January 17, 2024

Via Benzinga

Chart Of The Day: Elanco Animal Health- Big Money In Animal Pharma ↗

January 10, 2024

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 08, 2024

Via Benzinga

Stifel: ‘Party Is Just Getting Started’ In This Stock That's Up 80% ↗

January 07, 2024

Animal-pharma company Elanco Animal Health, once a subsidiary of Lilly, looks especially good with its new treatment for parvovirus in dogs.

Via Talk Markets

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday ↗

January 05, 2024

U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply during Friday’s session following upbeat...

Via Benzinga

Topics Stocks

Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From Elanco Animal Health Incorporated

Via Business Wire

Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference

November 27, 2023

From Elanco Animal Health Incorporated

Via Business Wire

Why Elanco Animal Health Stock Was Pure Catnip to Investors This Week ↗

November 10, 2023

Investors were cheered not only by the company's third-quarter double beat, but by guidance that was revised for the better.

Via The Motley Fool

Elanco Animal Health (ELAN) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

ELAN earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Fur-casting Success: Elanco Animal Health Tails Ahead with Raised Revenue Outlook, Stock Soars ↗

November 07, 2023

Elanco Animal Health Inc (NYSE: ELAN) reported a Q3 FY23 revenue of $1.068 billion, up 4% reported growth or 5% excluding the impact of foreign exchange rates, above the

Via Benzinga

Elanco Animal Health Reports Third Quarter 2023 Results

November 07, 2023

From Elanco Animal Health Incorporated

Via Business Wire

Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction

November 02, 2023

From Elanco Animal Health Incorporated

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 23, 2023

Via Benzinga

Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement

October 17, 2023

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Announces Corporate Governance Enhancements

October 04, 2023

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease

September 07, 2023

From Elanco Animal Health Incorporated

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.